Drug Profile
HIV vaccine - VAXXIT
Alternative Names: PreVaxTatLatest Information Update: 31 Oct 2021
Price :
$50
*
At a glance
- Originator VAXXIT
- Class AIDS vaccines
- Mechanism of Action Env gene product inhibitors; Immunostimulants; Tat gene product inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported HIV infections
Most Recent Events
- 28 May 2019 No recent reports of development identified for phase-I development in HIV-infections(Prevention, In volunteers) in Italy
- 29 Apr 2016 Phase-I clinical trials in HIV infections (In volunteers, Prevention) in Italy (unspecified route)
- 29 Apr 2016 Preclinical trials in HIV infections in Italy (Prevention) (unspecified route)